IL17A and systemic sclerosis: discovered that IL-17A from SSc patients could induce the proliferation, migration and collagen synthesis of DVSMCs via ERK1/2 signaling pathway (49), IL-17A exerts its pro-fibrotic role in endothelial inflammation in a dose- and time-dependent pattern (49).